Hypomethylation of 111 Probes Predicts Poor Prognosis for Glioblastoma

Hypomethylation of 111 Probes Predicts Poor Prognosis for Glioblastoma

Glioblastoma (GBM) is a complicated brain tumor with heterogeneous outcome. Identification of effective biomarkers is an urgent need for the treatment decision-making and precise evaluation of prognosis. Based on a relatively large dataset of genome-wide methylation (138 glioblastoma patients), a jo...

Full description

Bibliographic Details
Main Authors: Qi Chen, Min Zhao, Chengliang Yin, Shiyu Feng, Jian Hu, Qiang Zhang, Xiaodong Ma, Wanguo Xue, Jinlong Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Neuroscience
Subjects:
glioblastoma
biomarker
methylation
joint-score
prognostic evaluation
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2019.01137/full

Internet

https://www.frontiersin.org/article/10.3389/fnins.2019.01137/full

Similar Items